20.10.2024, 938 Zeichen

Valneva: Austrian/French Valneva SE, a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Shigella4V (S4V), the world's most clinically advanced tetravalent bioconjugate shigellosis vaccine candidate, for which Valneva obtained an exclusive worldwide license from LimmaTech. Fast Track designation is granted by the FDA to products under development that have the potential to treat serious conditions and fill an unmet medical need. It is designed to facilitate the clinical development and expedite the review of important new products with the intention to get them to the people who need them earlier.
Valneva: weekly performance: 5.89%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (17/10/2024)

Christian Drastil: Wiener Börse Plausch

Books from Friends #2: Liverpool .Die Geschichte eines Fremden, der sich in Klub und Stadt verliebte (David Aichinger)

Bildnachweis

Aktien auf dem Radar:Polytec Group, AT&S, Kapsch TrafficCom, Austriacard Holdings AG, Semperit, Amag, Rosgix, Agrana, Mayr-Melnhof, Uniqa, Frequentis, EVN, Lenzing, Gurktaler AG Stamm, Gurktaler AG VZ, Marinomed Biotech, Palfinger, Porr, SBO, Strabag, voestalpine, FACC, BKS Bank Stamm, CPI Europe AG, Österreichische Post, Telekom Austria, UBM, Deutsche Boerse, MTU Aero Engines, Zalando, Airbus Group.

---